Material Safety Data Sheet

Product No. 26933 KODAK DEKTOL Developer

Issue Date (01-26-07)

Review Date (06-19-07)

Section 1: Product and Company Identification

Product Name: KODAK DEKTOL Developer

Synonym: PCD 224

Supplier: Eastman Kodak Company, Rochester, New York, 14650

Company Name

Ted Pella, Inc. and PELCO International, P.O. Box 492477, Redding, CA 96049-2477
Domestic Phone  (800) 237-3526 (Mon-Thu. 6:00AM to 4:30PM PST; Fri 6:00AM to 4:00PM PST)

International Phone (01) (530) 243-2200 (Mon-Thu. 6:00AM to 4:30PM PST; Fri 6:00AM to 4:00PM PST)

Chemtrec Emergency Number 1-800-424-9300 24 hrs a day.

Section 2: Composition / Information on Ingredients

Concentrate: Principle Hazardous Component(s) (chemical and common name(s)) (Cas. No)	%	OSHA PEL mg/m3	ACGIH  TLV mg/m3	NTP	IARC	OSHA regulated
Sodium carbonate, monohydrate (5968-11-6)	50-55	NE	NE	No	No	No
Sodium sulfite (7757-83-7)	30-35	NE	NE	No	No	No
Hydroquinone (123-31-9)	5-10	2	2 *Group 3	No	No	No
Bis(4-hydroxy-N-methylanilinium) sulphate (55-55-0)	1-5	NE	NE	No	No	No
Potassium bromide  (7758-02-3)	1-5	NE	NE	No	No	No

 * Confirmed animal carcinogen with unknown relevance to humans. 

Section 3: Hazard Identification

 Emergency overview

Appearance: White solid.

Immediate effects: Warning! May cause blood disorders based on animal data. May cause kidney damage based on animal data. May cause cyanosis based on animal data. Harmful if inhaled or swallowed. May liberate sulfur dioxide. Dust, mist or vapor irritating to the eyes and respiratory tract. Repeated exposure to dust may cause eye injury. Causes skin and eye irritation. May cause allergic skin reaction.

Potential health effects

Primary Routes of entry: Eye and skin contact, inhalation, ingestion.
Signs and Symptoms of Overexposure:
Eyes: Causes eye irritation. Repeated exposure to dust may cause eye injury.

Skin: Causes skin irritation. May cause allergic skin reaction.

Ingestion: Harmful if swallowed.

Inhalation: Harmful if inhaled. Dust irritating to the respiratory tract.

Chronic Exposure: May cause blood disorders and cyanosis based on animal data.

Chemical Listed As Carcinogen Or Potential Carcinogen: None.

See Toxicological Information (Section11)

Potential environmental effects

See Ecological Information (Section 12)

Section 4: First Aid Measures
If accidental overexposure is suspected

Eye(s) Contact: In case of contact, immediately flush eyes with plenty of water for at least 15 minutes. Get medical attention.

Skin Contact: In case of contact, immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Get medical attention if symptoms occur. Wash contaminated clothing before re-use. Destroy or thoroughly clean contaminated shoes.

Inhalation: If inhaled, move to fresh air. Get medical attention if symptoms occur.

Ingestion: If swallowed, only induce vomiting as directed by medical personnel. Never give anything by mouth to an unconscious person. Call a physician or poison control center immediately.

Note to physician: Treatment: Absorption of this material into the body leads to the formation of methemoglobin that, in sufficient concentration, causes cyanosis. Since reversion of methemoglobin to hemoglobin occurs spontaneously after termination of exposure, moderate degrees of cyanosis need to be treated only

by supportive measures such as bed rest and oxygen inhalation. Thorough cleansing of the entire contaminated area of the body, including scalp and nails, is of utmost importance. If cyanosis is severe, intravenous injection of methylene blue, one milligram per kilogram of body weight, may be of value.

Medical Conditions generally Aggravated by Exposure:

Section 5: Fire Fighting Measures
Flash Point: NA
Flammable Limits: Not specified

Auto-ignition point: NA
Fire Extinguishing Media: Use extinguishing measures that are appropriate to local circumstances and the surrounding environment.

Special Fire Fighting Procedures: Wear self-contained breathing apparatus and protective clothing. Fire or excessive heat may produce hazardous decomposition products
Unusual Fire and Explosion Hazards: None

Hazardous combustion products: None (noncombustible)

DOT Class: Not regulated

Section 6: Accidental Release Measures
Steps to be Taken in Case Material is Released or Spilled: Shovel into suitable container for disposal. Avoid dust formation. Clean surface thoroughly to remove residual contamination.

Waste Disposal Methods: Dispose of waste according to Federal, State and Local Regulations.

Section 7: Handling and Storage
Precautions to be Taken in Handling and Storage: Do not breathe dust. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Use only with adequate ventilation. Wash thoroughly after handling. Keep container tightly closed. Keep away from incompatible substances

Storage temperature: Ambient

Storage Pressure: NA

Section 8: Exposure Controls / Personal Protection

Chemical Name          Regulatory List                     Value Type                                        Value

Hydroquinone               ACGIH                                   Time weighted average                         2 mg/m3

OSHA Z1                                Permissible exposure limit                     2 mg/m3

Sulphur dioxide             ACGIH                                    Time weighted average                         2 ppm

ACGIH                                    Short term exposure limit                      5 ppm

OSHA Z1                                Permissible exposure limit                     5 ppm 13 mg/m3

Engineering Controls

Ventilation required: Use process enclosures, local exhaust ventilation, or other engineering controls to maintain airborne levels below recommended exposure limits. Controls should be sufficient so that applicable occupational exposure limits are not exceeded.

Personal Protection Equipment

Respiratory protection: If engineering controls do not maintain airborne concentrations below recommended exposure limits, an approved respirator must be worn. Respirator type: full-face cartridge respirator with acid gas cartridge and N95 filter. A respirator should be worn if hazardous decomposition products are likely to be or have been released. Respirator type: Acid gas. See Stability and Reactivity Section. If respirators are used, a program should be instituted to assure compliance with applicable federal, state, commonwealth, provincial, or local laws and regulations.

Protective gloves: Wear impervious gloves.
Skin protection: Appropriate protective clothing.
Eye protection: Wear safety glasses with side shields (goggles).

Additional clothing and/or equipment: Safety shower, eye wash, washing facilities as appropriate to condition of use.

Exposure Guidelines

See Composition/Information on Ingredients (Section2)

Section 9 Physical and Chemical Properties
Appearance and Physical State: White solid (powder or granules)

Odor (threshold): Odorless

Specific Gravity (H2O=1): NE

Vapor Pressure (mm Hg): Negligible.

Vapor Density (air=1): NA

Percent Volatile by volume: Negligible.

 

Evaporation Rate (butyl acetate=1): ND

Boiling Point: NA.

Freezing point / melting point: NA
pH: NA
Solubility in Water: Appreciable.
Molecular Weight: NA

Section 10: Stability and Reactivity
Stability: Stable under normal conditions.
Conditions to Avoid: Incompatible materials

Materials to Avoid (Incompatibility): Acids. Contact with strong acids liberates sulfur dioxide
Hazardous Decomposition Products: Carbon dioxide, carbon monoxide, sulfur dioxide.
Hazardous Polymerization: Will not occur.

Section 11: Toxicological Information

Results of component toxicity test performed:

Data for Sodium carbonate, monohydrate (CAS 5968-11-6): Acute Toxicity Data: Oral LD50: 1,600 - 3,200 mg/kg. Skin irritation: slight

Data for Sodium sulphite (CAS 7757-83-7): Acute Toxicity Data: Oral (Rat) LD50: >1600 mg/Kg. Skin irritation: none. Eye irritation: slight; washing palliative

Data for Hydroquinone (CAS 123-31-9): Acute Toxicity Data:  Oral LD50 (rat): 400 mg/kg.  Oral LD50 (male rat): 400 mg/kg. Oral LD50 (male mouse): 100 - 200 mg/kg.  Dermal LD50 (guinea pig): > 1,000 mg/kg.  Dermal absorption rate: 1.1 micrograms (s) / cm 2 / hour. Skin irritation: slight.  Skin Sensitization: positive.  Eye irritation: moderate. Mutagenicity/Genotoxicity Data:  Salmonella typhimurium assay (Ames test): negative (in presence and absence of Chromosomal aberration assay: negative (in absence of activation) Chromosomal aberration assay: positive (in presence of activation) Sister chromatid exchange (SCE) assay: positive (in presence and absence of activation) Definitions for the following section(s): LOEL =lowest-observed-effect level, LOAEL = lowest observed-

adverse-effect, NOAEL = no observed-adverse-effect level, NOEL =no-observed-effect level. Repeated dose toxicity:  Dermal (17-day, rat): NOEL; 3800 mg/kg/day.  Dermal (17-day): LOEL (Lowest observable effect level); 4800 mg/kg/day. Developmental Toxicity Data:  Oral (female rabbit): NOEL for developmental toxicity; 25mg/kg/day.

There is insufficient evidence for classifying hydroquinone as a suspected carcinogenic or mutagenic substance in humans. No increases in cancer rates were observed in an epidemiology study which looked at mortality among more than 800 persons employed primarily in the manufacture of hydroquinone. Carcinogenicity studies in animals were inconclusive. Rats and mice were given hydroquinone by stomach tube or at high concentrations in the diet. Responses were not consistent across route of exposure, species or sex. The International Agency for Research on Cancer (IARC) has classified hydroquinone in Group 3, i.e., "not classifiable" as a carcinogen. Hydroquinone is generally negative in bacterial mutagenicity tests; there is evidence for the clastogenicity (chromosome breakage) of hydroquinone in vivo and in vitro. The relevance of chromosomal effects in test animals in predicting human risk is unclear.

Contains: Bis(4-hydroxy-N-methylanilinium) sulphate. Based on animal data, may cause adverse effects on the following organs/systems: blood, kidney, spleen. Based on animal data this material can produce methemoglobin which, in sufficient concentration, causes cyanosis, a blue-gray discoloration of the skin and lips caused by a reduced ability of the blood to carry oxygen.

Data for Potassium bromide (CAS 7758-02-3): Acute Toxicity Data:  Oral LD50 (rat): > 1,600 mg/kg. Potassium bromide: Ingestion of bromide salts can cause nausea, vomiting, headache, irritability, delirium, memory loss, decreased appetite, joint pain, hallucinations, stupor, coma, and acne like rash on face, legs, and trunk.

Human experience: See listed components above.

This product does not contain any compounds listed by NTP or IARC or regulated by OSHA as a carcinogen.

Section 12: Ecological Information

Ecological Information: The following properties are ESTIMATED from the components of the preparations.

Potential Toxicity: Toxicity to fish (LC50): 1 - 10 mg/l. Toxicity to daphnia (EC50): < 1 mg/l. Toxicity to algae (IC50): 10 - 100 mg/l. Toxicity to other organisms (EC50): > 100 mg/l.

Persistence and degradability: Readily biodegradable

Chemical Oxygen Demand (COD): < 1 g/g

Biochemical Oxygen Demand (BOD): < 1 g/g

Chemical Fate Information: ND

Section 13 Disposal Considerations

RCRA 40 CFR 261 Classification: Discharge, treatment, or disposal may be subject to federal, state, commonwealth, provincial, or local laws. Since emptied containers retain product residue, follow label warnings even after container is emptied.

Federal, State and local laws governing disposal of materials can differ. Ensure proper disposal compliance with proper authorities before disposal.

Section 14: Transportation Information

US DOT Information: Proper shipping name: Not regulated

IATA: Proper shipping name: Not regulated

IMO: Proper shipping name: Not regulated

Marine Pollutant: ND

Canadian TDG: Not regulated

Section 15: Regulatory Information

United States Federal Regulations

MSDS complies with OSHA’s Hazard Communication Rule 29, CFR 1910.1200.

SARA: Section 302: No chemical in this material subject to reporting.

SARA Title III: Section 313: Hydroquinone (123-31-9).

RCRA: Not listed

TSCA:  Not listed

CERCLA: Hydroquinone (123-31-9): RQ = 100 lbs (45.4 kg).

Notification status:

Regulatory List:                     Notification status:   Other information:                 Not listed:

EINECS                                  n (Negative listing)        -                                               Sodium carbonate, monohydrate

TSCA                                      n (Negative listing)        Not On TSCA Inventory          Sodium carbonate, monohydrate

AICS                                       y (positive listing)          -

DSL                                        n (Negative listing)        This product contains the          Sodium carbonate, monohydrate

following components that are

not on the Canadian DSL nor

NDSL lists.

ENCS (JP)                               n (Negative listing)        -                                               Sodium carbonate, monohydrate

KECI (KR)                              n (Negative listing)        -                                               Sodium carbonate, monohydrate

PICCS (PH)                            y (positive listing)          -

INV (CN)                                y (positive listing)          -

A n (Negative listing) indicates one or more component is either not on the public Inventory or is subject to exemption requirements. If additional information is needed contact Kodak.

State Regulations

California Proposition 65: None.

International Regulations

Canada WHMIS: Materials on this product are listed in the CPR Inventory List.

Europe EINECS Numbers: Sodium carbonate, monohydrate (5968-11-6): EINECS#: 207-838-8 Sodium sulfite (7757-83-7): EINECS#: 231-821-4. Hydroquinone (123-31-9): EINECS#: 204-617-8. Bis(4-hydroxy-N-methylanilinium) sulphate (55-55-0): EINECS#: 200-237-1. Potassium bromide (7758-02-3): EINECS#: 231-830-3.

Section 16: Other Information

Label Information: CONTAINS: Sodium carbonate, monohydrate (5968-11-6), Sodium sulphite (7757-83-7), Hydroquinone (123-31-9), Bis(4-hydroxy-N-methylanilinium) sulphate (55-55-0), Potassium bromide (7758-02-3)

European Risk and Safety Phrases: ND

European symbols needed: ND

Canadian WHMIS Symbols: ND

NFPA Hazard Rating: Health: 2; Fire: 0; Reactivity: 0

NOTE: NFPA 704 (2007) hazard indexes involves data review and interpretation that may vary among companies. It is intended only for rapid, general identification of the magnitude of the potential hazards. To adequately address safe handling, ALL information in this MSDS must be considered.

(0=least, 1=Slight, 2=Moderate, 3=High, 4=Extreme)

Abbreviations used in this document

NE= Not established

NA= Not applicable

NIF= No Information Found

ND= No Data

Disclaimer
Ted Pella, Inc. makes no warranty of any kind regarding the information furnished herein. Users should independently determine the suitability and completeness of information from all sources. While this data is presented in good faith and believed to be accurate, it should be considered only as a supplement to other information gathered by the user. It is the User's responsibility to assure the proper use and disposal of these materials as well as the safety and health of all personnel who may work with or otherwise come in contact with these materials.

 

MSDS Form 0013F1 V2